MoneyWorks4Me

Abbott India informs about disclosure of related party transactions

25 Nov 2022 Evaluate

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022. The above disclosure is also available on the website of the Company at www.abbott.co.in.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..